Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Medicine » Cardiovascular Disorders » Percutaneous Valve Technology: Present and Future Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Central Asia: Perspectives and Present Challenges
$160.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Transcatheter valve-in-valve for failed bioprosthetic valves (pp. 307-326)
Tell A Friend
 
Tell someone you know about this product.
Transcatheter valve-in-valve for failed bioprosthetic valves (pp. 307-326) $100.00
Authors:  (Gurvitch R, Je J, Cheung A and John Webb)
Abstract:
All bioprosthetic heart valves, if given sufficient time, can be expected to eventually fail. Despite this, such valves are often favored over mechanical versions to avoid anticoagulation and the associated increased risk of bleeding[1] [2]. When bioprosthetic valves degenerate, repeat cardiac surgery is often at an increased risk given the nature of re-do cardiac surgery and the frequently advanced age of patients requiring such operations [3]. Certain co-morbidities such as advanced age, reduced ejection fraction, pulmonary disease and length of cardiopulmonary bypass time have been identified as independent predictive factors of poor outcomes following re-do surgery for failed aortic and mitral bioprostheses [4] [5].
In recent years, transcatheter heart valve (THV) implantation for stenosed native aortic valves has evolved as a viable alternative to open heart surgery particularly in high-risk surgical patients[6-8] [9] [10] [11] [12] [13]. As experience with the procedure widened and clinical outcomes improved, the concept of treating surgically degenerated valves using similar transcatheter techniques became a possibility. Such treatment is often referred to as ―valve-in-valve‖ (VIV) implantation, as the new THV is implanted inside the degenerated bioprosthesis. In this chapter, we will review the techniques, outcomes and challenges of VIV therapy for failed surgical bioprostheses in the aortic, mitral, tricuspid and pulmonary positions. 


Available Options:
Version:
This Item Is Currently Unavailable.
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2019

Transcatheter valve-in-valve for failed bioprosthetic valves (pp. 307-326)